C-reactive protein and the risk of cancer: A mendelian randomization study

Journal of the National Cancer Institute

Volumn 102, Issue 3, 2010, Pages 202-206

  Allin, Kristine H ^a,d   Nordestgaard, Børge G ^a,b,d   Zacho, Jeppe ^a,d   Tybjærg Hansen, Anne ^a,b,c,d   Bojesen, Stig E ^a,b,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CLINICAL STUDY; DNA SEQUENCE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAZARD RATIO; HOMOZYGOSITY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TURBIDIMETRY;

ADULT; AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 76349122909     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp459     Document Type: Article

References (27)

1. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009;27(13):2217-2224.
2. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA. 2004;291(5): 585-590. (Pubitemid 38500312)
3. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res. 2006;66(4):2483-2487.
4. Il'yasova D, Colbert LH, Harris TB, et al. Circulating levels of infammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2413-2418.
5. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-Based Prospective Study. Cancer Epidemiol Biomarkers Prev. 2006;15(4):690-695.
6. Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006;24(33): 5216-5222.
7. Trichopoulos D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P. Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev. 2006;15(2):381-384.
8. Davey SG, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1-22.
9. Frikke-Schmidt R, Nordestgaard BG, Stene MC, et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA. 2008;299(21):2524-2532.
10. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009;301(22):2331-2339.
11. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008; 27(8):1133-1163.
12. Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008; 359(18):1897-1908.
13. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299-308.
14. Schnohr P, Jensen JS, Scharling H, Nordestgaard BG. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from the Copenhagen City Heart Study. Eur Heart J. 2002;23(8): 620-626.
15. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and effcacy of record linkage procedures. Int J Epidemiol. 1988;17(1):44-49.
16. Storm HH. The Danish Cancer Registry a self-reporting national cancer registration system with elements of active data collection. IARC Sci Publ. 1991;95:220-236.
17. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry\-history, content, quality and use. Dan Med Bull. 1997; 44(5):535-539.
18. Third Report of the Expert Committee on Health Statistics.Geneva, Switzerland: World Health Organization; 1952. Report No. 53.
19. International Classifcation of Diseases and Related Health Problems, 10th Revision. 2nd ed. Geneva, Switzerland: World Health Organization; 2004.
20. Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005; 77(1):64-77.
21. Miller DT, Zee RY, Suk DJ, et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet. 2005;69(pt 6):623-638.
22. Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4): 341-353.
23. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301-1309.
24. Coussens LM, Werb Z. Infammation and cancer. Nature. 2002;420(6917):860- 867.
25. Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med. 2005;142(6): 425-432.
26. Engels EA. Infammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008;8(4):605-615.
27. Zhang SM, Lin J, Cook NR, et al. C-reactive protein and risk of breast cancer. J Natl Cancer Inst. 2007;99(11):890-894.